Abdoli Shadbad, Mahdi, Amir Baghbanzadeh, and Behzad Baradaran. “Hsa-MiR-34a-5p Enhances Temozolomide Anti-Tumoral Effects on Glioblastoma: In-Silico and in-Vitro Study”. EXCLI Journal 23 (March 13, 2024): 384–400. Accessed March 16, 2026. https://www.excli.de/excli/article/view/6404.